JM Smucker
SJM
115.93
-0.87
-0.74%
JM Smucker
US · SJM
#1264 by market cap
Listed 1970
115.93
-0.87
-0.74%
Live - 5344 symbols - heartbeat 335s ago
· 2026-10-08 07:37
Pre-market
115.93
0.00%
After-hours
115.93
0.00%
- Market cap
- 12.38B
- P/E (TTM)i
- 54.17
- P/Bi
- 2.15
- EPSi
- -1.30
- Div yieldi
- 3.80%
- 52W posi
- 60%
Reader sentiment
Are you bullish or bearish on SJM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.48, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.72% YoY
Margins
- Gross margin
- 33.53%
- Operating margin
- 14.84%
- Net margin
- -1.53%
Key ratios & quality
- Enterprise valuei
- 19.29B
- Altman Z-Scorei
- 1.48
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.84B | 7.80B | 8.00B | 8.00B | 8.53B | 8.18B | 8.73B | 9.05B |
| Gross profit | 2.92B | 3.00B | 3.14B | 2.70B | 2.80B | 3.12B | 3.38B | 3.03B |
| Selling & admin expenses | 1.51B | 1.47B | 1.52B | 1.36B | 1.46B | 1.45B | 1.53B | 1.50B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.20B | 1.29B | 1.39B | 1.17B | 1.18B | 1.45B | 1.65B | 1.34B |
| Pretax profit | 701.60M | 1.03B | 1.17B | 843.80M | -9.20M | 996.40M | -1.05B | -62.40M |
| Tax | 187.20M | 247.20M | 295.60M | 212.10M | 82.10M | 252.40M | 184.00M | 76.30M |
| Net profit | 514.40M | 779.50M | 876.30M | 631.70M | -91.30M | 744.00M | -1.23B | -138.70M |
| Basic EPS | 5 | 7 | 8 | 6 | -1 | 7 | -12 | -1 |
| Diluted EPS | 4.52 | 6.84 | 7.79 | 5.83 | -0.86 | 7.13 | -11.57 | -1.30 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 2.14B | 2.11B | 2.33B | 2.34B | 2.27B | 2.22B |
| Gross profit | 823.30M | 474.70M | 869.90M | 827.80M | 862.10M | 979.60M |
| Selling & admin expenses | 380.60M | 377.40M | 398.20M | 363.20M | 357.80M | 410.50M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 387.90M | 51.60M | 424.10M | 418.30M | 449.00M | 512.20M |
| Pretax profit | -697.10M | -56.50M | 318.40M | -651.90M | 327.60M | 427.90M |
| Tax | 31.90M | -12.60M | 77.10M | 72.30M | -60.50M | 103.60M |
| Net profit | -729.00M | -43.90M | 241.30M | -724.20M | 388.10M | 324.30M |
| Basic EPS | -7 | 0 | 2 | -7 | 4 | 3 |
| Diluted EPS | -6.85 | -0.41 | 2.26 | -6.79 | 3.64 | 3.03 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.63B | 1.97B | 1.94B | 2.01B | 2.86B | 1.97B | 2.15B | 1.97B |
| Cash & ST investments | 101.30M | 391.10M | 334.30M | 169.90M | 1.14B | 62.00M | 69.90M | 58.60M |
| Inventory | 910.30M | 895.30M | 959.90M | 1.09B | 1.01B | 1.04B | 1.21B | 1.13B |
| Total assets | 16.71B | 16.97B | 16.28B | 16.06B | 14.99B | 20.27B | 17.56B | 16.22B |
| Total current liabilities | 2.34B | 1.59B | 2.87B | 1.95B | 1.99B | 3.76B | 2.65B | 2.54B |
| Short-term debt | 1.22B | 284.50M | 1.28B | 220.10M | 33.20M | 1.59B | 640.80M | 570.90M |
| Long-term debt | 4.69B | 5.37B | 3.52B | 4.31B | 4.31B | 6.77B | 7.04B | 6.39B |
| Total liabilities | 8,740,800,000.00 | 8,779,500,000.00 | 8,159,400,000.00 | 7,914,900,000.00 | 7,700,600,000.00 | 12,579,800,000.00 | 11,480,700,000.00 | 10,675,600,000.00 |
| Total equity | 7.97B | 8.19B | 8.12B | 8.14B | 7.29B | 7.69B | 6.08B | 5.54B |
| Retained earnings | 2.37B | 2.75B | 2.85B | 2.89B | 2.13B | 2.19B | 501.80M | -101.30M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 2.15B | 2.40B | 2.33B | 1.99B | 1.97B | 1.99B |
| Cash & ST investments | 69.90M | 39.30M | 62.80M | 52.80M | 58.60M | 43.20M |
| Inventory | 1.21B | 1.39B | 1.35B | 1.17B | 1.13B | 1.19B |
| Total assets | 17.56B | 17.74B | 17.63B | 16.27B | 16.22B | 16.20B |
| Total current liabilities | 2.65B | 2.95B | 2.63B | 2.36B | 2.54B | 2.29B |
| Short-term debt | 640.80M | 951.60M | 748.20M | 486.90M | 570.90M | 343.50M |
| Long-term debt | 7.04B | 7.04B | 7.04B | 6.84B | 6.39B | 6.39B |
| Total liabilities | 11,480,700,000.00 | 11,816,000,000.00 | 11,568,100,000.00 | 11,029,600,000.00 | 10,675,600,000.00 | 10,452,400,000.00 |
| Total equity | 6.08B | 5.93B | 6.06B | 5.24B | 5.54B | 5.75B |
| Retained earnings | 501.80M | 343.50M | 468.20M | -372.80M | -101.30M | 103.60M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.14B | 1.25B | 1.57B | 1.14B | 1.19B | 1.23B | 1.21B | 1.47B |
| Depreciation & amortization | 446.30M | 446.50M | 452.50M | 459.10M | 431.00M | 430.80M | 502.50M | 557.00M |
| Free cash flow | 781.40M | 985.50M | 1.26B | 718.80M | 717.00M | 642.90M | 816.60M | 1.16B |
| Dividends paid | -377.90M | -396.80M | -403.20M | -418.10M | -430.20M | -437.50M | -455.40M | -464.70M |
| Stock buybacks / issuance | -5.40M | -4.20M | -678.40M | -270.40M | -367.50M | -372.80M | -3.30M | -5.60M |
| Ending cash balance | 101.30M | 391.10M | 334.30M | 169.90M | 655.80M | 62.00M | 69.90M | 58.60M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 393.90M | -10.60M | 346.50M | 558.50M | 579.20M | 425.70M |
| Depreciation & amortization | 123.40M | 135.20M | 143.30M | 144.10M | 134.40M | 127.50M |
| Free cash flow | 298.90M | -94.90M | 280.20M | 487.00M | 483.90M | 337.30M |
| Dividends paid | -114.50M | -114.40M | -116.80M | -116.70M | -116.80M | -116.80M |
| Stock buybacks / issuance | -200.00K | -4.60M | -400.00K | -200.00K | -400.00K | -5.70M |
| Ending cash balance | 69.90M | 39.30M | 62.80M | 52.80M | 58.60M | 43.20M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 6.45 | 9.59 | 10.70 | 7.75 | -1.18 | 9.93 | -17.87 | -2.39 |
| ROA %i | 3.20 | 4.60 | 5.25 | 3.90 | -0.59 | 4.22 | -6.51 | -0.82 |
| ROIC %i | 4.99 | 6.60 | 7.44 | 5.82 | 0.24 | 6.73 | -6.30 | 0.68 |
| 5-year avg ROE %i | 9.68 | 10.47 | 10.66 | 10.51 | 6.66 | 7.36 | 1.86 | -0.75 |
| EBIT margin %i | 11.60 | 15.59 | 16.86 | 12.56 | 1.67 | 15.41 | -7.54 | 3.52 |
| FCF / sales %i | 9.97 | 12.63 | 15.72 | 8.99 | 8.41 | 7.86 | 9.36 | 12.77 |
| Current ratioi | 0.69 | 1.24 | 0.68 | 1.03 | 1.44 | 0.52 | 0.81 | 0.78 |
| Quick ratioi | 0.26 | 0.59 | 0.30 | 0.36 | 0.88 | 0.21 | 0.26 | 0.28 |
| Debt / assetsi | 35.37 | 34.05 | 30.12 | 28.69 | 29.51 | 41.96 | 44.19 | 43.71 |
| LT debt / equityi | 58.80 | 67.07 | 44.67 | 53.89 | 60.23 | 89.91 | 117.07 | 117.57 |
| Interest coveragei | 4.37 | 6.43 | 7.62 | 6.24 | 0.94 | 4.77 | -1.69 | 0.84 |
| Revenue CAGR (3Y) %i | 0.11 | 1.81 | 2.84 | 0.68 | 3.02 | 0.73 | 2.94 | 2.00 |
| Net income CAGR (3Y) %i | -9.27 | 9.59 | -13.17 | 7.09 | -- | -5.31 | -- | -- |
| FCF CAGR (3Y) %i | -14.71 | 4.38 | 11.98 | -2.75 | -10.06 | -20.06 | 4.34 | 17.27 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | -17.87 | -21.32 | -17.44 | -20.68 | -2.39 | 3.93 |
| ROA %i | -6.51 | -7.66 | -6.34 | -7.24 | -0.82 | 1.35 |
| ROIC %i | -6.30 | -7.59 | -5.92 | -7.43 | 0.68 | 3.36 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -7.54 | -11.03 | -8.08 | -7.84 | 3.52 | 8.58 |
| FCF / sales %i | 9.36 | 7.72 | 7.24 | 10.88 | 12.77 | 17.35 |
| Current ratioi | 0.81 | 0.81 | 0.89 | 0.84 | 0.78 | 0.87 |
| Quick ratioi | 0.26 | 0.23 | 0.28 | 0.30 | 0.28 | 0.29 |
| Debt / assetsi | 44.19 | 45.55 | 44.89 | 45.83 | 43.71 | 42.57 |
| LT debt / equityi | 117.07 | 120.30 | 118.24 | 133.06 | 117.57 | 113.96 |
| Interest coveragei | -1.69 | -2.47 | -1.83 | -1.81 | 0.84 | 2.16 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- U.S. Retail Coffee is the largest reported line at 36.40% of revenue, across 6 reported segments.
- No single line clears half of revenue; U.S. Retail Frozen Handheld and Spreads is next at 22.50%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
U.S. Retail Coffee36.40%
U.S. Retail Frozen Handheld and Spreads22.50%
U.S. Retail Pet Foods16.75%
Sweet Baked Snacks10.66%
Away From Home9.18%
Other4.52%
Quote time 2026-10-08 07:37:25 · For reference only, not investment advice and not tailored to your situation.